Content area
Full Text
Contract notice: Medicines with the active ingredient distigmin (atc: n07aa03)
The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Para. 8 sgb v on medicinal products with the designation of active substance distigmine (atc: n07aa03) as part of a so-called "open-house model". Subject to uniform contractual conditions and a uniform access procedure, all suitable and interested pharmaceutical companies or associations of pharmaceutical companies can conclude or join a discount agreement in accordance with Section 130 a Para. 8 sgb v for the active ingredients listed under section b. Interested pharmaceutical companies can request the participation documents and the respective contract from...